In contrast, CD19+CD79A+ B cells (cluster 9, 17, 18, 20) only accounted for 3.41 ± 2.78% and 7.04 ± 5.52% of total cells from BD and VKHD samples, respectively (Figure 1c–e). This evidence concerns the gene CD79A and Behcet disease.